| abstract |
The invention provides binding molecules, such as TCRs or antigen-binding fragments thereof, as well as antibodies and antigen-binding fragments thereof, such as those recognizing or binding to human papillomavirus (HPV) 16, including HPV16 E6 and HPV16 E7. The invention also relates to genetically modified cells containing said binding molecules, compositions containing said binding molecules or genetically modified cells, and methods of treatment, for example, by administering said binding molecules, genetically modified cells, or compositions. |